Bobak R. Azamian - Aug 6, 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: President and CEO, Director
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol: TARS
Transactions as of: Aug 6, 2021
Transactions value $: -$61,088
Form type: 4
Date filed: 8/10/2021, 04:53 PM
Previous filing: Aug 6, 2021
Next filing: Aug 12, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$40.4K	-1.62K	-0.13%	$25.00	1.23M	Aug 6, 2021	By the Bobak Azamian Living Trust established April 16, 2018	F1, F2
transaction	TARS	Common Stock	Sale	-$18.2K	-727	-0.06%	$25.00	1.23M	Aug 9, 2021	By the Bobak Azamian Living Trust established April 16, 2018	F1, F2
transaction	TARS	Common Stock	Sale	-$2.51K	-100	-0.01%	$25.13	1.23M	Aug 9, 2021	By the Bobak Azamian Living Trust established April 16, 2018	F1, F2
holding	TARS	Common Stock						1.75K	Aug 6, 2021	Direct

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021.
F2	The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.